Victoza Prescription in Sherman, Texas at DFWPMA

Looking for a Victoza prescription in Sherman, Texas? Victoza (liraglutide) is a prescription GLP-1 medication used to treat type 2 diabetes. It requires careful medical evaluation because inappropriate prescribing or inadequate monitoring can lead to serious health complications.

At DFW Physicians Medical Associates (DFWPMA), our endocrinology and primary care providers conduct comprehensive evaluations of diabetes, metabolic health, medical history, and treatment risks to determine whether Victoza is safe and appropriate for each patient.

DFWPMA offers Victoza prescription evaluations in Sherman and can prescribe Victoza to eligible patients when medically appropriate. Victoza is FDA-approved to improve blood sugar control in adults and children aged 10 years and older with type 2 diabetes. It is also approved to reduce the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.

Book an appointment online or call (903) 957-0082 to contact our Sherman location.
Address: 📍
425 N Highland Ave., Suite 260, Sherman, TX 75092

Click here to get directions

We accept many major insurance plans. Not sure if your plan is accepted?

Call (903) 957-0082 and our team can help verify coverage.

Why Choose DFWPMA for a Victoza Prescription in Sherman, Texas?

DFW Physicians Medical Associates provides Victoza prescription evaluations in Sherman through providers experienced in endocrinology, diabetes care, metabolic disorders, and chronic disease management. Our multispecialty approach supports individualized diabetes treatment and ongoing medical supervision.

Patients seeking a Victoza prescription at DFWPMA can benefit from:

  • Experienced Medical Providers: Access to endocrinology and primary care providers experienced in diabetes management, metabolic health, and medication evaluations.
  • Comprehensive Eligibility Assessment: Reviewing diabetes status, medical history, current medications, and potential contraindications before prescribing Victoza.
  • Diabetes and Metabolic Health Evaluation: Assessing blood glucose, hemoglobin A1c, kidney function, and other relevant metabolic indicators.
  • Individualized Prescription Decisions: Developing recommendations according to diabetes treatment goals, medication history, clinical risks, and overall health.
  • Medication Safety Screening: Reviewing contraindications and precautions involving thyroid cancer history, pancreatitis, gastrointestinal disorders, gallbladder disease, and other relevant conditions.
  • Daily Injection Management: Providing guidance on Victoza administration, dose adjustments, injection technique, and medication tolerance.
  • Long-Term Diabetes Management: Monitoring blood sugar control, cardiovascular risk factors, treatment effectiveness, and chronic disease management.
  • Coordinated Multispecialty Care: Connecting patients with additional medical and behavioral health services when comprehensive diabetes-related support is needed.

Victoza is not appropriate for every patient with type 2 diabetes. Prescribing decisions require evaluating glycemic control, cardiovascular risk factors, potential adverse effects, contraindications, and alternative diabetes medications.

At DFWPMA Sherman, comprehensive medical evaluation and individualized treatment planning help determine whether Victoza is an appropriate diabetes medication.

Schedule an appointment with DFWPMA Sherman to discuss Victoza prescription eligibility and your diabetes treatment options.

Meet Our Victoza Prescription Providers in Sherman, Texas

DFWPMA Sherman offers Victoza prescription evaluations through endocrinology and primary care providers whose clinical experience includes diabetes management, metabolic disorders, and chronic disease care. These providers can assess medical eligibility and determine whether Victoza is appropriate.

Gitana Staskus, MD – Endocrinology

Dr. Gitana Staskus is a board-certified endocrinologist with more than 20 years of clinical experience diagnosing and treating endocrine and metabolic disorders in adults and older adults.

Her expertise includes type 1 and type 2 diabetes, gestational diabetes, weight management, metabolic disorders, thyroid conditions, hormone disorders, and osteoporosis. Dr. Staskus emphasizes individualized treatment planning, patient education, and long-term management of endocrine conditions.

Her specialized background in diabetes and metabolic health is particularly relevant for patients seeking Victoza prescription evaluations, including individuals with type 2 diabetes and additional metabolic conditions.

Aniwelyn Tan, DNP – Primary Care

Aniwelyn Tan is a primary care provider with more than 20 years of healthcare experience, including extensive experience managing chronic medical conditions and cardiovascular health concerns.

Her clinical expertise includes diabetes management, obesity, weight management, hypertension, internal medicine, and chronic disease treatment. She provides primary care for patients ages 15 and older.

Her experience in diabetes care and metabolic health supports Victoza prescription evaluations, including assessing glycemic control, reviewing medication safety, and developing individualized treatment plans.

Ayodya Perera, MD – Family Medicine

Dr. Ayodya Perera is a family medicine physician providing comprehensive primary care, preventive healthcare, and chronic disease management for patients ages 15 and older.

Dr. Perera’s clinical interests include diabetes management, weight management, hypertension, preventive medicine, and individualized medical treatment. The physician emphasizes shared decision-making and patient-centered healthcare.

This background in diabetes and chronic disease care is relevant to Victoza prescription evaluations, including reviewing blood sugar control, treatment eligibility, medication history, and long-term diabetes management goals.

Book an appointment online to inquire about Victoza prescription evaluations with DFWPMA’s medical providers in Sherman.

What Can a Victoza Prescription in Sherman, Texas Help With?

Victoza (liraglutide) is a once-daily injectable GLP-1 receptor agonist approved to improve blood sugar control in patients aged 10 years and older with type 2 diabetes. It also reduces the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.

At DFWPMA Sherman, Victoza prescription evaluations address:

  • Type 2 Diabetes Management: Improving blood sugar control in eligible patients with type 2 diabetes.
  • Elevated Hemoglobin A1c: Lowering A1c levels that exceed individualized diabetes treatment goals.
  • Cardiovascular Risk Reduction: Reducing major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
  • Blood Sugar Regulation: Improving glucose control through GLP-1 receptor activation.
  • Pediatric Type 2 Diabetes: Improving glycemic control in eligible children aged 10 years and older.
  • Complex Diabetes Treatment Needs: Evaluating Victoza when existing diabetes medications provide insufficient glycemic control.
  • Diabetes With Additional Metabolic Conditions: Managing type 2 diabetes alongside obesity, hypertension, or high cholesterol.

Victoza activates GLP-1 receptors, increasing glucose-dependent insulin secretion, reducing glucagon secretion, and slowing gastric emptying. These effects help improve blood sugar control in patients with type 2 diabetes.

The American Academy of Family Physicians recognizes GLP-1 receptor agonists as established noninsulin treatment options for type 2 diabetes, with medication selection based on effectiveness, safety, and individual patient needs.

Source: American Academy of Family Physicians – Management of Type 2 Diabetes Mellitus With Noninsulin Pharmacotherapy

Victoza is not indicated for type 1 diabetes and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN2. Important risks include pancreatitis, severe gastrointestinal reactions, dehydration-related kidney injury, gallbladder disease, and hypoglycemia when combined with certain diabetes medications.

Although some patients experience weight loss while taking Victoza, it is not specifically approved for chronic weight management. Saxenda contains the same active ingredient, liraglutide, but is approved for weight management in eligible patients.

Source: American College of Physicians – Pharmacologic Treatments for Overweight and Obesity

Schedule an appointment to discuss Victoza prescription eligibility at DFWPMA Sherman.

What Victoza Prescription Services Are Available at DFWPMA Sherman?

DFWPMA Sherman provides Victoza prescription evaluations, diabetes and metabolic testing, medication safety reviews, treatment planning, and ongoing monitoring through endocrinology and primary care providers.

Our Victoza prescription services include:

  • Initial Victoza Prescription Evaluation: Reviewing medical history, diabetes status, and treatment eligibility.
  • Diabetes and Metabolic Testing: Checking A1c, blood glucose, kidney function, and relevant metabolic markers.
  • Medication and Contraindication Review: Identifying medication interactions, contraindications, and potential health risks.
  • Victoza Prescription and Treatment Planning: Prescribing Victoza when medically appropriate and establishing diabetes management goals.
  • Starting Dose and Titration: Adjusting dosage according to prescribing guidance, treatment response, and tolerance.
  • Side Effect Monitoring: Assessing gastrointestinal symptoms, dehydration, and other adverse reactions.
  • Blood Sugar and Treatment Response Monitoring: Tracking glucose control, A1c changes, and medication effectiveness.
  • Long-Term Diabetes and Metabolic Care: Managing diabetes, cardiovascular risk factors, and related chronic conditions.
  • Alternative Diabetes Medication Evaluation: Considering other approved medications when Victoza is unsuitable.
  • Follow-Up and Coordinated Care: Providing continued medical supervision and specialty referrals when needed.

Victoza typically starts at 0.6 mg once daily for one week, followed by 1.2 mg daily. If additional blood sugar control is needed, the dose may increase to 1.8 mg daily after at least another week. The initial adult dose helps reduce gastrointestinal side effects rather than providing full glycemic control.

Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. Severe abdominal pain, significant dehydration, or allergic reactions require prompt medical attention.

The American Academy of Family Physicians emphasizes individualized diabetes medication selection based on effectiveness, safety, cardiovascular risk, and patient treatment goals.

Source: American Academy of Family Physicians – Management of Type 2 Diabetes Mellitus With Noninsulin Pharmacotherapy

Not every patient qualifies for Victoza. A medical evaluation determines whether the medication or an alternative diabetes treatment is appropriate. Victoza should not be combined with other liraglutide-containing medications, including Saxenda.

Looking for a Victoza prescription in Sherman, Texas? Book an appointment or call (903) 957-0082 to schedule your evaluation at DFWPMA.